申请人:Allergan, Inc.
公开号:US05231113A1
公开(公告)日:1993-07-27
Retinoid-like activity is exhibited by compounds of the formula ##STR1## where the R groups are independently hydrogen, or lower alkyl; A is --C(O)O--, --OC(O)--, --C(O)S--, or --SC(O)--; n is 0-5; and Z is H, --COB where B is --OH or a pharmaceutically acceptable salt, or B is --OR.sub.1 where R.sub.1 is an ester-forming group, or B is --N(R).sub.2 where R is hydrogen or lower alkyl, or Z is --OE where E is hydrogen or an ether-forming group or --COR.sub.2 where R.sub.2 is hydrogen, lower alkyl, phenyl or lower alkyl phenyl, or Z is --CHO or an acetal derivative thereof, or Z is --COR.sub.3 where R.sub.3 is --(CH.sub.2).sub.m CH.sub.3 where m is 0-4 and the sum of n and m does not exceed 4.
化合物的式子为##STR1##,其中R基可以独立地是氢或低碳基;A为--C(O)O--,--OC(O)--,--C(O)S--或--SC(O)--;n为0-5;Z为H,--COB,其中B为--OH或药用可接受盐,或B为--OR.sub.1,其中R.sub.1是酯基,或B为--N(R).sub.2,其中R为氢或低碳基,或Z为--OE,其中E为氢或醚基,或--COR.sub.2,其中R.sub.2为氢,低碳基,苯基或低碳基苯基,或Z为--CHO或其缩醛衍生物,或Z为--COR.sub.3,其中R.sub.3为--(CH.sub.2).sub.m CH.sub.3,其中m为0-4,n和m的总和不超过4,这些化合物表现出类视视黄醇的活性。